DRG 319

Surgical DRG

Other Endovascular Cardiac Valve Procedures with MCC

TypeSurgicalMDC05

What is MS-DRG 319?

MS-DRG 319 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 05 (MDC 05) with a Major Complication or Comorbidity (MCC). For FY 2026 it carries a relative weight of 4.4629 with a geometric mean length of stay of 7.4 days and an arithmetic mean of 10.2 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Surgical DRG
Procedure-driven grouping
Linked Codes
0 diagnosis
38 procedure

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
4.4629
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
7.4 days
Used for transfer payment calculations
Arithmetic Mean LOS
10.2 days
Average length of stay
Post-Acute Transfer
No
Not subject to the transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
319Other Endovascular Cardiac Valve Procedures with MCCThis page4.46297.4 days
320Other Endovascular Cardiac Valve Procedures without MCC2.40532.1 days

Linked ICD-10-PCS Procedure Mappings

  • 025F3ZZ

    Destruction of Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 025G3ZZ

    Destruction of Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 025H3ZZ

    Destruction of Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 025J3ZZ

    Destruction of Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 027F0ZZ

    Dilation of Aortic Valve, Open Approach

    BillableSection 0
  • 027G0ZZ

    Dilation of Mitral Valve, Open Approach

    BillableSection 0
  • 027H0ZZ

    Dilation of Pulmonary Valve, Open Approach

    BillableSection 0
  • 027J0ZZ

    Dilation of Tricuspid Valve, Open Approach

    BillableSection 0
  • 02BF3ZZ

    Excision of Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02BG3ZZ

    Excision of Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02BH3ZZ

    Excision of Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02BJ3ZZ

    Excision of Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02QF3ZJ

    Repair Aortic Valve created from Truncal Valve, Percutaneous Approach

    BillableSection 0
  • 02QF3ZZ

    Repair Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02QG3ZE

    Repair Mitral Valve created from Left Atrioventricular Valve, Percutaneous Approach

    BillableSection 0
  • 02QG3ZZ

    Repair Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02QH3ZZ

    Repair Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02QJ3ZG

    Repair Tricuspid Valve created from Right Atrioventricular Valve, Percutaneous Approach

    BillableSection 0
  • 02QJ3ZZ

    Repair Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02TH3ZZ

    Resection of Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02VG3ZZ

    Restriction of Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WF38Z

    Revision of Zooplastic Tissue in Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02WF3JZ

    Revision of Synthetic Substitute in Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02WF3KZ

    Revision of Nonautologous Tissue Substitute in Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02WG37Z

    Revision of Autologous Tissue Substitute in Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WG38Z

    Revision of Zooplastic Tissue in Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WG3JZ

    Revision of Synthetic Substitute in Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WG3KZ

    Revision of Nonautologous Tissue Substitute in Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WH37Z

    Revision of Autologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02WH38Z

    Revision of Zooplastic Tissue in Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02WH3JZ

    Revision of Synthetic Substitute in Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02WH3KZ

    Revision of Nonautologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02WJ37Z

    Revision of Autologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02WJ38Z

    Revision of Zooplastic Tissue in Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02WJ3JZ

    Revision of Synthetic Substitute in Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02WJ3KZ

    Revision of Nonautologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • X28F3VA

    Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10

    BillableSection X
  • X28F3WB

    Division of Aortic Valve using Leaflet Laceration, Radiofrequency Energy, Percutaneous Approach, New Technology Group 11

    BillableSection X